Sutro Biopharma

Don't miss it! Today, the STRO management team will present at the @CitizensBank Life Sciences Conference. Tune in via webcast here: event.summitcast.com/view/BuMiPNPty… $STRO #SutroBio

Jane Chung, Chief Executive Officer, will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference today, March 4th at 1:50PM EST. Click the link to register and join the live webcast: ir.sutrobio.com/events-present… #SutroBio $STRO

We look forward to attending the upcoming investor conferences. For more info: ir.sutrobio.com/press-releases… @TDBank_US @LeerinkPartners @CitizensBank @Barclays $STRO #SutroBio

We’re participating in the 16th Annual @World_ADC London Summit. Sutro CSO Hans-Peter Gerber will speak in three sessions on the evolving ADC landscape. More: ir.sutrobio.com/press-releases…

This week, Sutro announced a $110M financing, extending the company's cash runway and supporting continued advancement of our ADC pipeline and upcoming milestones. More details here: ir.sutrobio.com/press-releases… #SutroBio #CancerResearch $STRO

Join us today as Jane Chung, CEO of Sutro Biopharma, presents at the J.P. Morgan Healthcare Conference. We’ll be discussing our advancements in ADC technology and upcoming milestones. Tune in at 11:15AM PST / 2:15PM EST. ir.sutrobio.com/events-present… #JPM2026

We’re pleased to announce that our CEO, Jane Chung, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, Jan 15th at 11:15AM PST / 2:15PM EST. We look forward to sharing the latest on our novel ADC platform and our vision for the future of oncology. For more info: ir.sutrobio.com/press-releases… #JPM2026

We’re excited to welcome Kari Leetch to Sutro as our new SVP, Head of People & Culture. We’re thrilled to have her leadership and expertise on the team.

We’re excited to share that the first cohort of patients has been dosed in our Ph 1 trial of STRO-004, our next-gen TF-targeting exatecan ADC—an important step forward in advancing next-generation ADCs for patients. For more info: ir.sutrobio.com/news-events/ne… #SutroBio #CancerResearch $STRO

Jane Chung, Chief Executive Officer, will participate in the @Piper_Sandler 37th Annual Healthcare Conference on Dec 3rd at 3:30PM EST. For more information, ir.sutrobio.com/news-events/ev… #SutroBio #PSCHealthcare2025 #CancerResearch $STRO

We’re grateful to everyone who joined our virtual R&D Day yesterday! The discussion showcased how Sutro is redefining what’s possible in targeted oncology — from optimized payload design and differentiated target selection to growing clinical momentum. Watch the full replay here: event.choruscall.com/mediaframe/web… #SutroBio #CancerResearch #BiotechNews $STRO

Our virtual R&D Day starts today at 10 a.m. ET! Join us for a deep dive into our next-generation ADC platform and pipeline progress, including a detailed overview of our near- and long-term priorities and overall clinical strategy. Learn more about what’s being presented: ir.sutrobio.com/news-events/ne… Watch live here: event.choruscall.com/mediaframe/web… #SutroBio #CancerResearch $STRO

Today, we reported our Q3 2025 financial results and business highlights. The full press release can be found here ir.sutrobio.com/news-events/ne… #SutroBio #CancerResearch $STRO

Save the date! We’ll be hosting a virtual R&D Day next Wednesday, November 12, from 10 a.m. ET, where we’ll share new insights into our next-generation ADC platform, programs advancing toward the clinic, and our strategy to redefine targeted oncology therapies. More information here: ir.sutrobio.com/news-events/ne… #SutroBio #CancerResearch #CancerAwareness #Biotech #BiotechNews #SaveTheDate $STRO

Sutro Biopharma Announces Participation at the 16th Annual @World_ADC Conference. For more info, ir.sutrobio.com/news-events/ne…. #WADC25 #SutroBio #BiotechNews @HansonWade #CancerResearch $STRO

Excited to announce Hans-Peter Gerber, Chief Scientific Officer, and Barbara Leyman, Chief Business Officer, will participate in panel sessions at the 2nd Annual ADC & Novel Conjugates Partnering & Investment Summit next week. Contact us if you’d like to meet. @HansonWade #SutroBio #oncology #BusinessDevelopment #ADC #CancerResearch STRO

Pleased to announce, Jane Chung, Chief Executive Officer, will participate during the 2025 @WellsFargo Healthcare Conference on September 3rd at 2:15PM ET. For more info, ir.sutrobio.com/news-events/ev… #WellsFargo2025 #SutroBio #BioNews $STRO

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates. For more info, ir.sutrobio.com/news-events/ne… #FDA #SutroBio #BioNews $STRO

Huge thanks to @Nature and @AsherMullard for the recent article spotlighting Hans-Peter Gerber, CSO at Sutro Biopharma, in the feature: “Dual-Payload ADCs Move into First Oncology Clinical Trials.” The piece offers a thoughtful look at how combining two distinct payloads in a single ADC may unlock new potential in targeted cancer therapies. nature.com/articles/d4157… #ADC #CancerResearch #Biotech #Nature #SutroBio $STRO

Happy 4th of July! Wishing you a day filled with celebration, reflection, and connection. Stay safe and enjoy the holiday! #SutroBio $STRO #IndependenceDay #July4th 🇺🇸🎇